Main Considerations of Cardiogenic Shock and Its Predictors: Systematic Review
Autor: | Victor Rodrigues Ribeiro Ferreira, Giovanni Braile Sternieri, Eliana Migliorini Mustafa, Cibele Olegário Vianna Queiroz, Maria Christiane Valéria Braga Braile-Sternieri, Bethina Canaroli Sbardellini, Lúcia Angélica Buffulin de Faria, Idiberto José Zotarelli Filho, Domingo Marcolino Braile, Sofia Braile Sabino |
---|---|
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
Cardiac index Infarction Review Acute myocardial infarction 030204 cardiovascular system & hematology Angina 03 medical and health sciences Clinical trials 0302 clinical medicine Oliguria Internal medicine medicine 030212 general & internal medicine Myocardial infarction Cardiogenic shock biology business.industry medicine.disease Troponin Blood pressure CKMB biology.protein Cardiology Lactate medicine.symptom Cardiology and Cardiovascular Medicine business Biomarkers |
Zdroj: | Cardiology Research |
ISSN: | 1923-2837 1923-2829 |
DOI: | 10.14740/cr715w |
Popis: | The mortality rate of post-infarction cardiogenic shock (CS) was 80.0-90.0%. Recent studies show a significant reduction of hospital mortality to approximately 50.0%. CS is defined as systemic tissue hypoperfusion resulting from systolic and/or diastolic heart dysfunction, the main cause of which is acute myocardial infarction (AMI). The main predictors are biological markers such as troponin, CKMB and lactate. A systematic literature review and meta-analysis is performed in order to present and correlate the main literary findings on CS and its evolution with possible changes in biomarkers such as troponin, lactate and CKMB. After criteria of literary search with the use of the mesh terms: cardiogenic shock; acute myocardial infarction; biomarkers; troponin; CKMB; lactate; clinical trials and use of the bouleanos “and” between the mesh terms and “or” among the historical findings. In the main databases such as Pubmed, Medline, Bireme, EBSCO, Scielo, etc., a total of 96 papers that were submitted to the eligibility analysis were collated and, after that, 41 studies were selected, following the rules of systematic review - PRISMA (Transparent reporting of systematic reviews and meta-analyzes-http://www.prisma-statement.org/). Some risk factors for its development in AMI are advanced age, female gender, anterior wall infarction, diabetes mellitus, systemic arterial hypertension, previous history of infarction and angina. The CS associated with AMI depends on its extent and its complications, being the main ones: mitral regurgitation, rupture of the interventricular septum and rupture of the free wall of the left ventricule. The diagnosis is based on the clinical manifestations, such as mental confusion, oliguria, hypotension, tachycardia, fine pulse, sweating, and cold extremities; in hemodynamic aspects: systolic blood pressure was < 90.0 mm Hg or 30 mm Hg below baseline, pulmonary capillary pressure was > 18.0 mm Hg and cardiac index was < 2.2 L/min/m2. Laboratory and imaging exams should be requested to evaluate the possible etiology of CS, its systemic repercussions and comorbidities. The treatment aims at the rapid reestablishment of the blood flow in the affected artery, to improve the patient’s prognosis. The biomarkers dosage in the daily clinical practice of the different cardiological centers can facilitate the diagnosis and the conduction of the dubious cases and the best evaluation of the degree of myocardial suffering after CS. |
Databáze: | OpenAIRE |
Externí odkaz: |